Annual Drug Patent Expirations for TRICOR Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. It is available from six suppliers. There are…
The post New patent expiration for Abbvie drug TRICOR appeared first on DrugPaten…
Annual Drug Patent Expirations for TRICOR Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. It is available from six suppliers. There are…
The post New patent expiration for Abbvie drug TRICOR appeared first on DrugPaten…
Annual Drug Patent Expirations for ZECUITY Zecuity is a drug marketed by Teva Branded Pharm and is included in one NDA. There are ten patents protecting this drug. This drug…
The post New patent expiration for Teva Branded drug ZECUITY appeared first o…
New patent expiration for Teva Branded drug ZECUITY Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Astrazeneca drug DALIRESP appear…
New patent expiration for Astrazeneca drug DALIRESP Read Post »
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Eagle Pharms drug RYANODEX appeared first …
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 8,017,150 Expiration: Feb 13, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug …
Drug Patent Expirations for the Week of February 12, 2023 Read Post »
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Indivior Inc drug SUBOXONE appeared firs…
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
Annual Drug Patent Expirations for LEXAPRO Lexapro is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Allergan drug LEXAPRO appeared first…
Annual Drug Patent Expirations for LEXAPRO Lexapro is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Allergan drug LEXAPRO appeared first…